For years, PCR was the workhorse of molecular diagnostics—fast, reliable, and cost-effective. But as the demand for comprehensive genomic information grows, next-generation sequencing (NGS) is becoming the growth engine of the DNA diagnostics market. NGS enables the simultaneous analysis of hundreds or thousands of genes, supports the detection of complex variants, and provides the kind of broad genomic data that personalised medicine requires. Its rise is reshaping both clinical workflows and the competitive landscape.

The DNA Diagnostics Market illustrates this shift clearly: PCR remains the largest technology segment, but NGS is the fastest-growing, projected to expand from USD 3.0 billion in 2024 to USD 8.0 billion by 2035. The driver is the collapsing cost of sequencing—down from thousands of dollars to a few hundred per genome—which has made NGS accessible to routine clinical use. Applications include comprehensive genomic profiling in oncology, rare disease diagnosis, prenatal testing, and pharmacogenomics.

Other technologies remain relevant. Microarray offers cost-effective targeted analysis; Sanger sequencing remains a gold standard for confirming single variants; and CRISPR-based approaches are emerging at the frontier. But the strategic momentum is with NGS. For diagnostic laboratories, the implication is investment in bioinformatics, data storage, and interpretation capacity—capabilities that are becoming as important as sequencing hardware itself. As hospitals emerge as the fastest-growing end-use segment and genetic testing expands rapidly, NGS will increasingly determine which laboratories and platforms are positioned to serve the next phase of the market's growth toward USD 25.0 billion by 2035.

People Also Ask

• Is NGS replacing PCR?
  Not replacing it entirely. PCR remains dominant for targeted tests, but NGS is the fastest-growing technology for comprehensive genomic analysis.

• What is NGS used for in diagnostics?
  NGS is used for comprehensive genomic profiling, rare disease diagnosis, prenatal testing, and pharmacogenomics.

Tags: #NextGenerationSequencing #NGS #DNADiagnostics #PCR #GenomicProfiling #PrecisionMedicine